SP1 and neoplasm: This strategy was used to generate a conditionally replicating virus containing the GaLV FMG under regulation of the MLP, with E1 expression controlled by a tumor-selective promoter containing eight E2F-binding sites and one specificity protein 1 (Sp1)-binding, designated ICOVIR16.